A research team from two London universities have developed a multi-layer device that addresses the instability of organic ...

Akebia Therapeutics faces a 28% stock drop amid financial woes, declining revenues, and competitive challenges. Read more on ...

However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

For example, VELPHORO (Sucroferric Oxyhydroxide Chewable Tablets), used for phosphorus reduction in chronic kidney disease (CKD) patients, is the first iron-based, non-calcium phosphate binder (PB ...

[SMM Analysis]Industry Dilemma Under High Copper Prices: Dual Decline in Operating Rates of Copper Cathode Rod and Secondary Copper Rod, Inventory Accumulation Prices fluctuated in the morning session ...

Change orientation to land scape to view the price table ...